Polyethyleneimine

Modify Date: 2024-01-02 19:40:49

Polyethyleneimine structure	Common Name	Polyethyleneimine
	CAS Number	9002-98-6	Molecular Weight	43.06780
	Density	1.030 g/mL at 25 °C	Boiling Point	250 °C(lit.)
	Molecular Formula	C₂H₅N	Melting Point	59-60°C
	MSDS	Chinese USA	Flash Point	>230 °F
	Symbol	GHS07, GHS09	Signal Word	Warning

Use of Polyethyleneimine

Polyethylenimine is a class of cationic polymers, is effective for gene delivery. Polyethylenimine is nondegradable and the molecular weight of PEI affects the cytotoxicity and gene transfer activity. Polyethylenimine acts as a low toxicity and efficient gene vector[1].

Name	Polyethylenimine, branched
Synonym	More Synonyms

Description	Polyethylenimine is a class of cationic polymers, is effective for gene delivery. Polyethylenimine is nondegradable and the molecular weight of PEI affects the cytotoxicity and gene transfer activity. Polyethylenimine acts as a low toxicity and efficient gene vector[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
References	[1]. Yuting Wen, et al. A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector. Bioconjug Chem. 2009 Feb;20(2):322-32.

Density	1.030 g/mL at 25 °C
Boiling Point	250 °C(lit.)
Melting Point	59-60°C
Molecular Formula	C₂H₅N
Molecular Weight	43.06780
Flash Point	>230 °F
Exact Mass	43.04220
PSA	21.94000
Appearance of Characters	Liquid \| Pale yellow
Index of Refraction	n20/D 1.5290
Storage condition	2-8°C
Water Solubility	Soluble in water.

Symbol	GHS07, GHS09
Signal Word	Warning
Hazard Statements	H302-H411
Precautionary Statements	P273
Personal Protective Equipment	Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
Hazard Codes	Xn,N,Xi
Risk Phrases	22-43-51/53-36/38
Safety Phrases	22-24/25-61-36/37-37-26
RIDADR	UN 3082 9 / PGIII
WGK Germany	2
RTECS	TQ7917000
Hazard Class	9.0

Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment.

Oncotarget 6 , 10548-62, (2015)

Treatment options for ovarian cancer patients remain limited and overall survival is less than 50% despite recent clinical advances. The lipid phosphatase inositol polyphosphate 4-phosphatase type II ...

MFCD00084427

Aziridine, homopolymer